To the Editor.—
In the December 1976 issue of the Archives (112:1757-1760), Drs Robinson and Samorodin presented a case report entitled "Thiabendazole-Induced Toxic Epidermal Necrolysis." The clinical presentation began initially with typical bullous erythema multiforme. This progressed to the picture of toxic epidermal necrolysis. The authors raised the issue of this conjunction. Moreover, they raised the interesting point that the immunologically changed lymphocyte may release a pharmacologically active agent that damages the epidermis.
Yaffee HS. Bullous Erythema Multiforme. Arch Dermatol. 1977;113(11):1613-1614. doi:10.1001/archderm.1977.01640110133040